Biomedical Research Excellence

Who We Are

  • Established in the fall of 2000 under the NIH Institutional Development Award (IDeA) program.
  • Combines the expertise of Nebraska’s leading biomedical research institutions: University of Nebraska-Lincoln, University of Nebraska Medical Center, and Creighton University.
  • Research programs focus on important viral diseases of humans, including HIV-1, Kaposi’s Sarcoma and herpes, as well as viruses within plants and animals.
  • Supported by the Center’s four core facilities: Flow Cytometry, Proteomics, Microscopy, and Bioinformatics.
  • Faculty engage in mentoring young scientists and students from the U.S. and abroad and seek to attract more researchers to Nebraska.


Register for the symposium in virology

Symposium flyer

19th Annual Symposium in Virology
4th annual Prem S. Paul Memorial Virology Symposium
September 6, 2019
Nebraska Union
University of Nebraska-Lincoln


NSF-funded workshop targets microbe-infecting viruses

An upcoming workshop at the University of Nebraska–Lincoln will assemble national experts on the viruses that infect microorganisms — including the microbes responsible for more than half of the planet’s oxygen.

NU again lands in world’s top 100 for U.S. patents


The University of Nebraska system ranked among the top 100 academic institutions worldwide in earning U.S. patents during 2018, the second straight year it has received the distinction for legally protecting research discoveries and technological innovations.

Myron Brakke Exhibit

Myron Brakke, the first Nebraskan elected into the National Academy of Sciences, is honored by an exhibit displaying the first-ever high speed swing bucket rotor that he designed, developed and help manufacture that was central his most notable accomplishment of developing density gradient centrifugation for the purification and characterization of viruses and macromolecules.  The exhibit displays the rotor, information on his life and scientific career, as well as information on significant contributions of Nebraskan scientists to the field of virology. The exhibit was conceived, designed and developed in a collaborative effort of students, staff and faculty in the first-of-its-kind course entitled “Exhibits”. The exhibit is on permanent display in the Ken Morrison Life Sciences Research Center at the University of Nebraska-Lincoln, home of the Nebraska Center for Virology.

March for Science April 22, 2017

March for Science

On Saturday April 22nd, people around the world marched for science. Lincoln was no exception with an estimated 2500 participants. Our own members of the NCV were key contributors to the March for Science Lincoln.

$1.3M NIH grant to aid study of plants’ viral defense

Wenjin Fan, Qingsheng Li, Zhe Yuan and Guobin Kang

Hernan Garcia-Ruiz did not understand why the farmers could no longer grow the tomatoes and peppers and beans that had once fed their small town north of Mexico City. He was a child then, watching the farmers reluctantly abandon their favored crops for corn and wheat.

Study confirms simian ancestors of HIV can infect human cells

Wenjin Fan, Qingsheng Li, Zhe Yuan and Guobin Kang.

No one knows exactly how it happened. It may have entered through a cut or bite wound, the blood of a chimpanzee seeping into an exposed fingertip or forearm or foot.

Dr. Asit Pattnaik interviewed by 10/11 about Zika virus

Asit Pattnaik

The Zika Virus has been around since the 1940s, generally in Africa, but it has not been studied in depth. Now though, researchers are hitting the ground running as the virus has spread like wildfire through areas in South and Latin America, and over the last several weeks, multiple cases have been reported.

Nutech Ventures - Breakthrough of the Year


The Breakthrough Innovation of the Year award, which was presented to Hiep Vu, Fernando Osorio, Asit Pattnaik and Fangrui Ma for their PRSS Vaccine. The PRSS Vaccine creates a method for the development of a porcine reproductive and respiratory virus vaccine strain capable of inducing broad protection. Current vaccines on the market only protect against a specific strain of the virus, which costs the swine industry more than $640 million a year.